Scientists discover why ozempic may not work for some people

Scientists have identified genetic variants that may reduce the effectiveness of GLP-1 drugs for treating Type 2 diabetes in about 10% of the population. These variants appear to cause 'GLP-1 resistance,' making carriers less likely to achieve healthy blood sugar targets during clinical trials of these medications.